Covestor’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70K Buy
211
+148
+235% +$50.4K 0.05% 481
2025
Q4
$25K Sell
63
-209
-77% -$92.5K 0.01% 1179
2025
Q3
$124K Sell
272
-69
-20% -$28.1K 0.07% 449
2025
Q2
$111K Sell
341
-74
-18% -$20.5K 0.07% 485
2025
Q1
$112K Sell
415
-43
-9% -$11.1K 0.07% 405
2024
Q4
$108K Buy
458
+1
+0.2% +$263 0.07% 480
2024
Q3
$126K Sell
457
-319
-41% -$83.1K 0.08% 390
2024
Q2
$189K Buy
776
+44
+6% +$6.95K 0.12% 175
2024
Q1
$110K Buy
732
+375
+105% +$62.6K 0.07% 475
2023
Q4
$68K Buy
357
+293
+458% +$49.9K 0.05% 707
2023
Q3
$11K Sell
64
-3
-4% -$572 0.01% 1356
2023
Q2
$13K Buy
67
+1
+2% +$198 0.01% 1312
2023
Q1
$13K Sell
66
-15
-19% -$3.15K 0.01% 1173
2022
Q4
$19K Sell
81
-314
-79% -$67K 0.02% 1042
2022
Q3
$79K Buy
395
+300
+316% +$57.2K 0.07% 477
2022
Q2
$14K Buy
95
+2
+2% +$284 0.01% 1076
2022
Q1
$15K Buy
93
+37
+66% +$5.64K 0.01% 1144
2021
Q4
$10K Buy
+56
New +$10.4K 0.01% 1010

Other funds holding ALNY